Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / COVID-19 - Page 68

COVID-19

Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19
COVID-19 | Life Science History | Vaccine

Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19

On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneメs single-dose intranasal vaccine…

Read More Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19Continue

Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
COVID-19 | FDA | Life Science History

Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2

On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…

Read More Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2Continue

A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
COVID-19 | Life Science History

A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment

On Jul. 22, 2020, a new study led by Albert Einstein College of Medicine and Montefiore Health System…

Read More A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatmentContinue

Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
COVID-19 | Therapeutics

Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19

On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…

Read More Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19Continue

RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
Biotechnology | COVID-19 | Therapeutics

RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico

On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…

Read More RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and MexicoContinue

Findings from real-world data study reveal higher risk of hospitalization and death among cancer patients with COVID-19
COVID-19 | FDA | Life Science History

Findings from real-world data study reveal higher risk of hospitalization and death among cancer patients with COVID-19

On Jul. 22, 2020, the FDA announced the data analyzed in collaboration with Syapse revealed a stark reality…

Read More Findings from real-world data study reveal higher risk of hospitalization and death among cancer patients with COVID-19Continue

Experimental Coronavirus vaccine is safe and produced immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental Coronavirus vaccine is safe and produced immune response

On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…

Read More Experimental Coronavirus vaccine is safe and produced immune responseContinue

Experimental coronavirus vaccine reported safe and produces immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental coronavirus vaccine reported safe and produces immune response

On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…

Read More Experimental coronavirus vaccine reported safe and produces immune responseContinue

Mesa Biotech received  $15.4 million funding from the NIH for accelerated scale-up and deployment
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH

Mesa Biotech received $15.4 million funding from the NIH for accelerated scale-up and deployment

On Jul. 21, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…

Read More Mesa Biotech received $15.4 million funding from the NIH for accelerated scale-up and deploymentContinue

Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples
COVID-19 | Life Science History

Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples

On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…

Read More Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samplesContinue

COVID-19 vaccine trials conducted at Washington University, Saint Louis University
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

COVID-19 vaccine trials conducted at Washington University, Saint Louis University

On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…

Read More COVID-19 vaccine trials conducted at Washington University, Saint Louis UniversityContinue

FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19
COVID-19 | Life Science History

FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19

On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…

Read More FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19Continue

Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program

On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…

Read More Valneva confirmed participation in UK Government COVID-19 Vaccine Response ProgramContinue

Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19
Biotechnology | COVID-19 | Therapeutics

Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19

On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…

Read More Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19Continue

Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line
COVID-19 | Life Science History

Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line

On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…

Read More Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell lineContinue

OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract
CDC | COVID-19 | Life Science History

OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract

On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced accepted an Indefinite Delivery Indefinite Quantity contract…

Read More OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contractContinue

Thermo Fisher Scientific’s to support development and production of  COVID-19 therapeutics and vaccines
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines

On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…

Read More Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccinesContinue

Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
COVID-19 | FDA | Life Science History

Luminex received FDA Emergency Use Authorization for COVID-19 antibody test

On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPᆴ…

Read More Luminex received FDA Emergency Use Authorization for COVID-19 antibody testContinue

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine

On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…

Read More The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccineContinue

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection
COVID-19 | Life Science History | Nanotechnology | Vaccine

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection

On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…

Read More HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injectionContinue

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials
COVID-19 | Life Science History | Vaccine

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials

On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…

Read More HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trialsContinue

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
COVID-19 | Life Science History | Vaccine

Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…

Read More Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19Continue

RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
Biotechnology | COVID-19 | Therapeutics

RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia

On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…

Read More RedHill Biopharma received approval for phase 2/3 COVID-19 study in RussiaContinue

Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19
COVID-19 | FDA | Life Science History

Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19

On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…

Read More Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIᆴ for treatment of COVID-19Continue

Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
COVID-19 | Genomics | Life Science History

Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research

On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…

Read More Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic researchContinue

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics

On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…

Read More Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeuticsContinue

Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
COVID-19 | Life Science History

Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19

On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…

Read More Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19Continue

BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
COVID-19 | Life Science History

BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment

On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…

Read More BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatmentContinue

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza

On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…

Read More Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenzaContinue

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore
COVID-19 | Life Science History

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore

On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinメs Office of the…

Read More Philanthropic gifts funded COVID-19 pilot research projects at Einstein and MontefioreContinue

Page navigation

Previous PagePrevious 1 … 66 67 68 69 70 … 99 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search